Literature DB >> 16543530

Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.

P M Candler1, R C Dale, S Griffin, A J Church, R Wait, M D Chapman, G Keir, G Giovannoni, J H Rees.   

Abstract

BACKGROUND: Adult opsoclonus-myoclonus (OM), a disorder of eye movements accompanied by myoclonus affecting the trunk, limbs, or head, is commonly associated with an underlying malignancy or precipitated by viral infection.
METHODS: We present the first two reports of post-streptococcal OM associated with antibodies against a 56 kDa protein. Two young girls presented with opsoclonus and myoclonus following a febrile illness and pharyngitis. Protein purification techniques were employed. Amino acid sequences of human neuroleukin (NLK) and streptococcal proteins were compared using the protein-protein BLAST application.
RESULTS: The antigen was identified as NLK (glucose-6-phosphate isomerase, GPI). GPI is present on the cell surface of streptococcus making the protein a candidate target for molecular mimicry.
CONCLUSIONS: We have identified NLK as an antigenic target in two patients with post-streptococcal OM. The pathogenicity of the antibodies is uncertain. The potential role of anti-neuroleukin antibodies in the pathogenesis of OM is discussed. We propose that OM may represent a further syndrome in the growing spectrum of post-streptococcal neurological disorders. The role of streptococcus in OM and the frequency with which anti-NLK responses occur in both post-infectious and paraneoplastic OM should be investigated further.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16543530      PMCID: PMC2077526          DOI: 10.1136/jnnp.2005.078105

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Dancing eyes-dancing feet.

Authors:  K E Imtiaz; J P Vora
Journal:  Lancet       Date:  1999-07-31       Impact factor: 79.321

Review 2.  Multifunctional alpha-enolase: its role in diseases.

Authors:  V Pancholi
Journal:  Cell Mol Life Sci       Date:  2001-06       Impact factor: 9.261

Review 3.  Opsoclonus-myoclonus syndrome following Epstein-Barr virus infection.

Authors:  Ashok Verma; Branimir Brozman
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

4.  Post-streptococcal autoimmune psychiatric and movement disorders in children.

Authors:  Russell C Dale; Isobel Heyman
Journal:  Br J Psychiatry       Date:  2002-09       Impact factor: 9.319

5.  Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.

Authors:  L Bataller; F Graus; A Saiz; J J Vilchez
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

6.  Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis.

Authors:  M E Gurney; A C Belton; N Cashman; J P Antel
Journal:  N Engl J Med       Date:  1984-10-11       Impact factor: 91.245

7.  Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein.

Authors:  A Haga; Y Niinaka; A Raz
Journal:  Biochim Biophys Acta       Date:  2000-07-14

8.  Autoantigen diversity in the opsoclonus-myoclonus syndrome.

Authors:  Luis Bataller; Myrna R Rosenfeld; Francesc Graus; Juan J Vilchez; Nai-Kong V Cheung; Josep Dalmau
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

9.  Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.

Authors:  Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

10.  Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency.

Authors:  W Kugler; K Breme; P Laspe; H Muirhead; C Davies; H Winkler; W Schröter; M Lakomek
Journal:  Hum Genet       Date:  1998-10       Impact factor: 4.132

View more
  8 in total

Review 1.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

2.  Opsoclonus-myoclonus-ataxia syndrome and HIV seroconversion.

Authors:  Ana Ayarza; Virginia Parisi; Javier Altclas; Daniela Visconti; Gabriel Persi; Carlos A Rugilo; Emilia M Gatto
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

3.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

4.  Commentary.

Authors:  Victoria Bîrluţiu
Journal:  J Neurosci Rural Pract       Date:  2014-11

5.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

6.  Scrub Typhus-Associated Opsoclonus: Clinical Course and Longitudinal Outcomes in an Indian Cohort.

Authors:  Ravikar Ralph; A T Prabhakar; Sowmya Sathyendra; Ronald Carey; John Jude; George M Varghese
Journal:  Ann Indian Acad Neurol       Date:  2019 Apr-Jun       Impact factor: 1.383

7.  Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report.

Authors:  Victoria Bîrluţiu; Rareş Mircea Bîrluţiu
Journal:  J Med Case Rep       Date:  2014-06-26

Review 8.  Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review.

Authors:  Jason L Chan; Keely A Murphy; Justyna R Sarna
Journal:  J Neurol       Date:  2021-02-22       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.